These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 833274

  • 1. Gastric emptying and secretion in Zollinger-Ellison syndrome.
    Dubois A, Eerdewegh PV, Gardner JD.
    J Clin Invest; 1977 Feb; 59(2):255-63. PubMed ID: 833274
    [Abstract] [Full Text] [Related]

  • 2. Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential.
    Sarosiek J, Jensen RT, Maton PN, Peura DA, Harlow D, Feng T, McCallum RW, Pisegna JR.
    Am J Gastroenterol; 2000 May; 95(5):1158-65. PubMed ID: 10811321
    [Abstract] [Full Text] [Related]

  • 3. [Hyperacidity and hypersecretion of the stomach stump--a possibility of Zollinger-Ellison syndrome].
    Lityński M, Altman W.
    Pol Tyg Lek; 1968 Oct; 23(44):1698-700. PubMed ID: 5701469
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of vagotomy in Zollinger-Ellison syndrome.
    Richardson CT, Feldman M, McClelland RN, Dickerman RM, Kumpuris D, Fordtran JS.
    Gastroenterology; 1979 Oct; 77(4 Pt 1):682-6. PubMed ID: 467924
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome.
    Raufman JP, Collins SM, Pandol SJ, Korman LY, Collen MJ, Cornelius MJ, Feld MK, McCarthy DM, Gardner JD, Jensen RT.
    Gastroenterology; 1983 Jan; 84(1):108-13. PubMed ID: 6128284
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M, Pospai D, Forestier S, Vatier J, Vallot T.
    Clin Ther; 1993 Jan; 15 Suppl B():22-31. PubMed ID: 8205592
    [Abstract] [Full Text] [Related]

  • 13. Metiamide treatment in five patients with Zollinger-Ellison syndrome.
    Bonfils S, Bernier JJ, Mignon M, Lambert R, Bernades P, L'Hirondel C, Accary JP, Kloeti G.
    Digestion; 1977 Jan; 15(1):43-52. PubMed ID: 838177
    [Abstract] [Full Text] [Related]

  • 14. Clinical recovery owing to target parietal cell failure in a patient with Zollinger-Ellison syndrome.
    Wiersinga WM, Tytgat GN.
    Gastroenterology; 1977 Dec; 73(6):1413-7. PubMed ID: 199524
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of gastric acid secretion by metiamide in Zollinger-Ellison syndrome.
    Mainardi M, Maxwell V, Sturdevant RA, Isenberg JI.
    Am J Dig Dis; 1975 Mar; 20(3):280-1. PubMed ID: 1124750
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Stimulation of gastric secretion after calcium infusion in the Zollinger-Ellison syndrome].
    Basso N, Passaro E, Lezoche E, Mennini G, Speranza V.
    J Chir (Paris); 1972 Mar; 103(5):493-8. PubMed ID: 4653425
    [No Abstract] [Full Text] [Related]

  • 19. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients.
    Ippoliti AF, Isenberg JI, Hagie L.
    Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412
    [Abstract] [Full Text] [Related]

  • 20. An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.
    Morocutti A, Merrouche M, Bjaaland T, Humphries T, Mignon M.
    Aliment Pharmacol Ther; 2006 Nov 15; 24(10):1439-44. PubMed ID: 17081164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.